Abstract
Introduction: Implantable cardioverter-defibrillator (ICD) therapy has been shown to improve survival in patients with structural heart disease and at high risk for life threatening ventricular arrhythmias. Whether elderly patients benefit from device therapy in a similar way as younger patients is largely unknown.
Methods: We retrospectively analyzed data from 375 consecutive ICD recipients with structural heart disease. Patients were divided into two groups, younger than 70 years at time of ICD implantation (group 1) or 70 years or older (group 2). Main outcome measures were time to death from any cause and time from first appropriate ICD therapy to death.
Results: Group 1 and 2 patients were comparable with respect to clinical presentation and average follow-up duration. In the elderly patient group, 78% received an ICD for secondary prevention versus 63% in group 1 (p = 0.007). During a mean follow-up period of 26.5 ± 18.1 months, there was no significant difference in overall mortality among the two groups: 47 patients died, 34 (12.5%) of group 1 versus 13 (12.7%) of group 2. The average time to death was 28.4 ± 16.7 vs 30.4 ± 22.1 months after device implantation, respectively (p = ns). There was no difference in time from device implantation to first adequate ICD therapy and time from first appropriate ICD therapy to death among the two groups (p = ns). Device associated complications were comparable in both groups.
Conclusions: Elderly ICD recipients had comparable survival rates and appropriate use of the ICD compared to younger individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337(22):1576–1583.
Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'BrienB. Canadian implantable defibrillator study (CIDS): A Randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302.
Kuck KH, Cappato R, Siebels J, Rüppel R, for the CASH Investigators. A randomized comparison of antiarrhythmic drug therapy with implantable defibrillators resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748–754.
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1933–1940.
Buxton AE, Lee KL, Fischer JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Eng J Med 1999;341:1882–1890.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–883.
Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Randomized trial of prophylactic implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481–2488.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, de Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–2150.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Andersen J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–237.
Tresch DD, Troup PJ, Thakur RK, Veseth-Rogers J, Tucker V, Wetherbee JN, Hoffmann RG, Chapmann PD. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med 1991;90:717–724.
Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S, Biehl M, Keelan ET, Jazayeri MR, Akhtar M, Dhala A: Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997;29: 556–560.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–170.
Ferrick KJ. Antiarrhythmic therapy in elderly persons: a device-based approach. Am J Geriatr Cardiol 2005;14:10–15.
Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Utilization and outcomes of the implantable cardioverter defibrillator, 1978 to 1995. Am Heart J 2002;144:397–403.
Quan KJ, Lee JH, Costantini O, Konstantakos AK, Murrell HK, Carlson MD, Mackall JA, Biblo LA, Geha AS. Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years. Ann Thorac Surg 1997;64:1713–1717.
Author information
Authors and Affiliations
Corresponding author
Additional information
There was no external financial support of this study.
Rights and permissions
About this article
Cite this article
Duray, G., Richter, S., Manegold, J. et al. Efficacy and Safety of ICD Therapy in a Population of Elderly Patients Treated with Optimal Background Medication. J Interv Card Electrophysiol 14, 169–173 (2005). https://doi.org/10.1007/s10840-006-5200-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-006-5200-y